Search details
1.
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.
N Engl J Med
; 384(12): 1125-1135, 2021 03 25.
Article
in English
| MEDLINE | ID: mdl-33577729
2.
Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.
J Urol
; 211(1): 90-100, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37788015
3.
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Cancer Immunol Immunother
; 72(3): 775-782, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-35998004
4.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Cancer
; 128(6): 1194-1205, 2022 Mar 15.
Article
in English
| MEDLINE | ID: mdl-34882781
5.
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Br J Cancer
; 126(3): 430-439, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35046520
6.
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.
Oncologist
; 27(5): e406-e409, 2022 05 06.
Article
in English
| MEDLINE | ID: mdl-35294031
7.
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trial.
Future Oncol
; 18(25): 2771-2781, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35703113
8.
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
Cancer
; 127(6): 840-849, 2021 03 15.
Article
in English
| MEDLINE | ID: mdl-33216356
9.
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Cancer
; 127(16): 2954-2965, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-33951180
10.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
BJU Int
; 128(5): 607-614, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33909949
11.
Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials.
Future Oncol
; 17(19): 2545-2558, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33783228
12.
A CD24-p53 axis contributes to African American prostate cancer disparities.
Prostate
; 80(8): 609-618, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32168400
13.
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Cancer
; 126(20): 4485-4497, 2020 10 15.
Article
in English
| MEDLINE | ID: mdl-32757302
14.
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
Cancer Immunol Immunother
; 69(11): 2305-2317, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32506263
15.
Systematic Review and Meta-Analysis-Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma?
J Urol
; 203(6): 1147-1155, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31928407
16.
Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Cancer
; 125(8): 1319-1329, 2019 04 15.
Article
in English
| MEDLINE | ID: mdl-30633323
17.
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
Cancer
; 125(4): 533-540, 2019 02 15.
Article
in English
| MEDLINE | ID: mdl-30570744
18.
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.
Oncologist
; 24(2): 202-210, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30190302
19.
Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection.
AJR Am J Roentgenol
; 212(5): 1060-1069, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30860885
20.
Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma.
J Urol
; 200(6): 1207-1214, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30012366